Keyphrases
Medical Oncology
88%
Cancer Treatment
88%
Blastic
88%
Interfollicular
88%
MR Spectroscopy Imaging
88%
Hodgkin Lymphoma
88%
Mantle Cell Lymphoma
88%
Advanced Solid Tumors
88%
Proton MR Spectroscopy
88%
Rhinocerebral mucormycosis
88%
Dose-escalation Study
88%
Paclitaxel
88%
Carboplatin
88%
Topotecan
88%
Magnetic Resonance Spectroscopy
88%
Magnetic Resonance Imaging
88%
Bone Marrow Biopsy
88%
Hematological Malignancies
88%
Flow Cytometric Immunophenotyping
88%
Bone Marrow Aspiration
88%
Granulocyte Colony-stimulating Factor (G-CSF)
74%
Maximum Tolerated Dose
74%
Leucine
59%
Bone Marrow
59%
Dose-limiting Toxicity
44%
Neutropenia
44%
Fine-needle Aspiration Biopsy
38%
Dry Tap
29%
Acetate
29%
Immunocompromised Patients
29%
Dose Escalation
29%
Essentially Similar
29%
Elevated Lactate
29%
Differential Diagnosis
29%
Valine
29%
Amino Acids
29%
Succinate
29%
Imaging Findings
29%
Abscess
29%
Extensive Literature Review
29%
Proton Magnetic Resonance Spectroscopy
29%
N-acetylaspartate
29%
Biopsy Specimen
29%
Lymphoma
25%
Advanced Performance
14%
Optimal Sequence
14%
Performance Status
14%
Starting Dose
14%
Partial Response
14%
Patients with Advanced Cancer
14%
Medicine and Dentistry
Biopsy Technique
100%
Medical Oncology
88%
Cancer Therapy
88%
Mucormycosis
88%
Hodgkin's Lymphoma
88%
Immunophenotyping
88%
Magnetic Resonance Imaging
88%
Mantle Cell Lymphoma
88%
Hematologic Malignancy
88%
Bone Marrow Biopsy
88%
NMR Spectroscopy
88%
Fine-Needle Aspiration
33%
Lactic Acid
22%
Metabolite
22%
Succinic Acid
22%
Leucine
22%
Abscess
22%
Differential Diagnosis
22%
Amino Acid
22%
Valine
22%
Magnetic Resonance Imaging
22%
Isoleucine
22%
Proton Nuclear Magnetic Resonance
22%
Acetic Acid
22%
N Acetylaspartic Acid
22%
Final Diagnosis
12%
Morphology
11%
Diagnosis
11%
Contralateral
11%
Cervical Lymphadenopathy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
88%
Topotecan
88%
Carboplatin
88%
Paclitaxel
88%
Mucormycosis
88%
Granulocyte Colony Stimulating Factor
74%
Maximum Tolerated Dose
74%
Neutropenia
44%
N Acetylaspartic Acid
29%
Valine
29%
Leucine
29%
Amino Acid
29%
Isoleucine
29%
Succinic Acid
29%
Abscess
29%
Lactic Acid
29%
Blood Clotting Factor 5
14%
Cytokine
14%
Phase I Trials
14%
Advanced Cancer
14%